123 related articles for article (PubMed ID: 9509607)
1. Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity.
Franklin CI; Parker CA; Morton KM
Australas Radiol; 1998 Feb; 42(1):58-65. PubMed ID: 9509607
[TBL] [Abstract][Full Text] [Related]
2. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire.
Nguyen LN; Pollack A; Zagars GK
Urology; 1998 Jun; 51(6):991-7. PubMed ID: 9609638
[TBL] [Abstract][Full Text] [Related]
3. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects.
Fransson P; Tavelin B; Widmark A
Support Care Cancer; 2001 May; 9(3):187-98. PubMed ID: 11401103
[TBL] [Abstract][Full Text] [Related]
4. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.
Crook J; Esche B; Futter N
Urology; 1996 Mar; 47(3):387-94. PubMed ID: 8633407
[TBL] [Abstract][Full Text] [Related]
5. [Quality of life after radiotherapy for prostate cancer].
Joly F; Degrendel AC; Guizard AV
Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
[TBL] [Abstract][Full Text] [Related]
6. Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer.
Emara AM; Chadwick E; Nobes JP; Abdelbaky AM; Laing RW; Langley SE
BJU Int; 2012 Apr; 109(7):994-1000. PubMed ID: 21854533
[TBL] [Abstract][Full Text] [Related]
7. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields.
al-Abany M; Helgason AR; Cronqvist AK; Svensson C; Wersäll P; Steineck G
Acta Oncol; 2002; 41(6):532-42. PubMed ID: 12546526
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
[TBL] [Abstract][Full Text] [Related]
9. Re: Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
Dalkin BL
J Natl Cancer Inst; 2001 Mar; 93(5):401-2. PubMed ID: 11238710
[No Abstract] [Full Text] [Related]
10. American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy.
Nag S; Ellis RJ; Merrick GS; Bahnson R; Wallner K; Stock R;
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):462-70. PubMed ID: 12243823
[TBL] [Abstract][Full Text] [Related]
11. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
Hanlon AL; Watkins Bruner D; Peter R; Hanks GE
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):51-9. PubMed ID: 11163497
[TBL] [Abstract][Full Text] [Related]
12. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
Lilleby W; Fosså SD; Waehre HR; Olsen DR
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
[TBL] [Abstract][Full Text] [Related]
13. Acute morbidity of radiation therapy for prostate carcinoma.
Franklin CI
Australas Radiol; 1996 May; 40(2):140-5. PubMed ID: 8687346
[TBL] [Abstract][Full Text] [Related]
14. Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up.
Lilleby W; Stensvold A; Dahl AA
Acta Oncol; 2014 Oct; 53(10):1380-9. PubMed ID: 24844918
[TBL] [Abstract][Full Text] [Related]
15. Scoring of treatment-related late effects in prostate cancer.
Livsey JE; Routledge J; Burns M; Swindell R; Davidson SE; Cowan RA; Logue JP; Wylie JP
Radiother Oncol; 2002 Nov; 65(2):109-21. PubMed ID: 12443807
[TBL] [Abstract][Full Text] [Related]
16. Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
Coen JJ; Paly JJ; Niemierko A; Weyman E; Rodrigues A; Shipley WU; Zietman AL; Talcott JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e201-9. PubMed ID: 21621343
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy in the treatment of carcinoma of the prostate.
Grayhack JT; Grout DC; Moss W; Holland JM
Trans Am Assoc Genitourin Surg; 1970; 62():172-8. PubMed ID: 5492389
[No Abstract] [Full Text] [Related]
18. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
[TBL] [Abstract][Full Text] [Related]
19. Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.
Veccia A; Caffo O; Fellin G; Mussari S; Ziglio F; Maines F; Tomio L; Galligioni E
Radiat Oncol; 2015 Jun; 10():130. PubMed ID: 26054532
[TBL] [Abstract][Full Text] [Related]
20. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls.
Fransson P; Widmark A
Cancer; 1999 Feb; 85(3):678-88. PubMed ID: 10091741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
